UV Shemesh presents Buxco's nose-only rodent inhalation system, highlighting how it can improve research efficiency and offer valuable insights into inhalation respiratory studies.
Inhalation delivery remains the preferred pre-clinical choice as it provides fast route to the blood stream with minimal side effects. However, the research itself contains several challenges that turns many researchers away from this delivery method. Over the past couple of years, several features have been added to Buxco’s nose-only inhalation system, improving on its flexibility and study optimization tools. In this webinar, UV Shemesh will introduce those features, discuss their practical benefits and applications, and demonstrate how they can simplify inhalation research while gaining important insights and efficiency.
Key Topics Include:
- Nebulizer calibration and regulation to ensure more reproducible aerosol deliveries
- Integration of plethysmography with animal restraint to optimize flow rate and contribute to long-term compound savings
- Tips to assess and optimize the tolerability of vehicle and test compounds using plethysmography
- How automated aerosol characterization can simplify the identification of optimal system conditions
- How gravimetric collection techniques can replace live digital aerosol concentration measurements to improve real-time dose reporting
- The use of delivered dose reports and respiratory endpoints to serve as predictive indicators for lung deposition through imaging technology
- Overview of SmartStudy’s capabilities, including:
- Automated aerosol delivery based on user-defined targets for dose or time
- Management of single or multiple-dosage groups
- Conducting T0 sacrifices without compromising chamber environment by staggering duration protocol
- Categories: Pharmacology, Respiratory Science, Toxicology
- Tags: inhalation exposure, plethysmography, respiratory function
Presenters
Production Partners
Data Sciences International
Data Sciences International (DSI) is the leader in preclinical physiological monitoring offering telemetry, instrumentation, software and services to help advance science. Industries served include: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, Medical Devices, Government, and Biotechnology.
Harvard Bioscience, Inc.
Harvard Bioscience is a global leader in the manufacturing and distribution of solutions to advance life science research. For over 110 years, we have served the changing needs of life scientists in over 100 countries. Our expanding portfolio of brands include instruments for organ and animal research, cell analysis, molecular biology, fluidics, and laboratory consumables.
Additional Content From Data Sciences International
Novel Animal Models and Methods for Studying COVID-19: Golden Hamsters and Aerosolized SARS-CoV-2 Delivery
Experts present two novel animal models of COVID-19 and highlight recent research conducted using these models.
Assessing Toxicity and Health Risks of E-cigarettes: How to Take Aim at a Moving Target
Dr. Emma Karey presents research that challenges the convention that extant cigarette endpoints sufficiently capture the health risks of vaping, and provides a translational framework for how to integrate scientific principles and novel conditions.
Continuous Glucose Monitoring and Glycemic Variability in Pregnancy
Join Caroline Wuyts, MSc for a deep dive into her research on pregnancy and monitoring glucose availability throughout the reproductive timeline of a mouse model.
Additional Content From Harvard Bioscience, Inc.
Molecule Transport across Cell Membranes: Electrochemical Quantification at the Microscale
In this webinar, Dr. Sabine Kuss discusses the importance of transmembrane molecule exchange and how to detect and quantify membrane transport of molecules in cells.
Cardiac Research Using Microelectrode Array Technology: Methodology Considerations and Best Practices to Optimize Recording
Join George Portugal, PhD for an overview of microelectrode array (MEA) technology used for cardiac research and some best practices for integrating this technique into your research.
A Novel Approach to Removing Urea from Dialysate: Methods and Validation by Amino Acid Quantification
Dr. Guozheng Shao and Dr. Anna Scott discuss the development of an osmotic membrane for use in a portable dialysis device and its validation using amino acid analysis to quantify urea removal using this novel membrane.
Related Content
Visualizing the Intracellular Immune Response to SARS-CoV-2 with Fast, High-Content Imaging
Experts discuss how automated microscopy and image analysis can quantify critical markers of infection and describe the insight provided by microscopy in the context of SARS-CoV-2 infection and inflammation.
Cutting Edge Conversations: Addressing COVID-19 During Uncertainty
Hayley Crawford, PhD, and Carl Marci, MD, discuss how their specific industries have developed new innovations in response to the COVID-19 pandemic.
Cardiovascular Disease Associated with SARS-CoV-2 and HIV Infections
Dr. Xuebin Qin discusses the development and characterization of new models of SARS-CoV-2 and HIV, and how his lab uses these models to study cardiovascular injury associated with infection.
Having issues registering with our form? Please Register Here